Inventor · disambiguated record
Sathyadevi Venkataramani
Also filed as: VENKATARAMANI SATHYADEVI
6 granted patents·16 pending applications·4 citations·filing 2018–2024
71Inventor score
Top patents by PatentIndex Score
22 records- 0179US11267880B2Anti-Sema3A antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Mar 8, 2022·1 cites·26 claims
- 0279US10793634B2Anti-TrkB antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Oct 6, 2020·3 cites·38 claims
- 0379US2023250171A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0479US2023365684A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0579US2023365683A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0675US2024336674A1Anti-sema3a antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0774US2024101689A1Anti-trkb antibodiesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0870US2024124583A1Proteins Comprising Kallikrein Related Paptidase 2 Antigen Binding Domains And Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0969US2024293453A1Materials and methods for binding siglec-3/cd33JANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1067US2022144929A1Anti-sema3a antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1164US2021130440A1Methods for producing biotherapeutics with increased stability by sequence optimizationJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1262US11866501B2Anti-TrkB antibodiesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 9, 2024·0 cites·1 claims
- 1361US12077585B2Proteins comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·0 cites·96 claims
- 1461US2025099635A1Iimmunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1556US2024025992A1Proteins comprising delta-like ligand 3 (dll3) antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1655US2022324970A1Materials and methods for multidirectional biotransportationJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1755US2025325718A1Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1855US2023019640A1Materials and methods for polymeric antibody receptor targetingJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1951US2022356266A1Biosynthetic glycoprotein populationsJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2050US11866499B2Monospecific and multispecific anti-TMEFF2 antibodies and their usesJANSSEN BIOTECH INC·Filed 2019·Granted Jan 9, 2024·0 cites·23 claims
- 2148US12071466B2Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereofJANSSEN BIOTECH INC·Filed 2020·Granted Aug 27, 2024·0 cites·35 claims
- 2245US2022305056A1Chimeric antigen receptor system and uses thereofJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sathyadevi Venkataramani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →